Search Results - "Evers, Melvin M."

Refine Results
  1. 1
  2. 2

    Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy by Martier, Raygene, Liefhebber, Jolanda M., García-Osta, Ana, Miniarikova, Jana, Cuadrado-Tejedor, Mar, Espelosin, Maria, Ursua, Susana, Petry, Harald, van Deventer, Sander J., Evers, Melvin M., Konstantinova, Pavlina

    Published in Molecular therapy. Nucleic acids (07-06-2019)
    “…A hexanucleotide GGGGCC expansion in intron 1 of chromosome 9 open reading frame 72 (C9orf72) gene is the most frequent cause of amyotrophic lateral sclerosis…”
    Get full text
    Journal Article
  3. 3

    Human Brain Organoids as Models for Central Nervous System Viral Infection by Depla, Josse A, Mulder, Lance A, de Sá, Renata Vieira, Wartel, Morgane, Sridhar, Adithya, Evers, Melvin M, Wolthers, Katja C, Pajkrt, Dasja

    Published in Viruses (18-03-2022)
    “…Pathogenesis of viral infections of the central nervous system (CNS) is poorly understood, and this is partly due to the limitations of currently used…”
    Get full text
    Journal Article
  4. 4

    A Perspective on Organoids for Virology Research by Sridhar, Adithya, Simmini, Salvatore, Ribeiro, Carla M S, Tapparel, Caroline, Evers, Melvin M, Pajkrt, Dasja, Wolthers, Katja

    Published in Viruses (23-11-2020)
    “…Animal models and cell lines are invaluable for virology research and host-pathogen interaction studies. However, it is increasingly evident that these models…”
    Get full text
    Journal Article
  5. 5

    Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-nuclear Transcripts in ALS and FTD Patients by Martier, Raygene, Liefhebber, Jolanda M., Miniarikova, Jana, van der Zon, Tom, Snapper, Jolanda, Kolder, Iris, Petry, Harald, van Deventer, Sander J., Evers, Melvin M., Konstantinova, Pavlina

    Published in Molecular therapy. Nucleic acids (01-03-2019)
    “…The most common pathogenic mutation in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is an intronic GGGGCC (G4C2) repeat in the…”
    Get full text
    Journal Article
  6. 6

    AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models by Spronck, Elisabeth A., Brouwers, Cynthia C., Vallès, Astrid, de Haan, Martin, Petry, Harald, van Deventer, Sander J., Konstantinova, Pavlina, Evers, Melvin M.

    “…Huntington disease (HD) is a fatal neurodegenerative disorder caused by an autosomal dominant CAG repeat expansion in the huntingtin (HTT) gene. The translated…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon by Evers, Melvin M, Tran, Hoang-Dai, Zalachoras, Ioannis, Pepers, Barry A, Meijer, Onno C, den Dunnen, Johan T, van Ommen, Gert-Jan B, Aartsma-Rus, Annemieke, van Roon-Mom, Willeke M.C

    Published in Neurobiology of disease (01-10-2013)
    “…Abstract Spinocerebellar ataxia type 3 is caused by a polyglutamine expansion in the ataxin-3 protein, resulting in gain of toxic function of the mutant…”
    Get full text
    Journal Article
  9. 9

    Targeting several CAG expansion diseases by a single antisense oligonucleotide by Evers, Melvin M, Pepers, Barry A, van Deutekom, Judith C T, Mulders, Susan A M, den Dunnen, Johan T, Aartsma-Rus, Annemieke, van Ommen, Gert-Jan B, van Roon-Mom, Willeke M C

    Published in PloS one (01-09-2011)
    “…To date there are 9 known diseases caused by an expanded polyglutamine repeat, with the most prevalent being Huntington's disease. Huntington's disease is a…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic by Miniarikova, Jana, Evers, Melvin M., Konstantinova, Pavlina

    Published in Molecular therapy (04-04-2018)
    “…The single mutation underlying the fatal neuropathology of Huntington’s disease (HD) is a CAG triplet expansion in exon 1 of the huntingtin (HTT) gene, which…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain by Zalachoras, Ioannis, Evers, Melvin M, van Roon-Mom, Willeke M C, Aartsma-Rus, Annemieke M, Meijer, Onno C

    Published in Frontiers in molecular neuroscience (01-01-2011)
    “…A limiting factor in brain research still is the difficulty to evaluate in vivo the role of the increasing number of proteins implicated in neuronal processes…”
    Get full text
    Journal Article
  19. 19

    Antisense oligonucleotides in therapy for neurodegenerative disorders by Evers, Melvin M., Toonen, Lodewijk J.A., van Roon-Mom, Willeke M.C.

    Published in Advanced drug delivery reviews (29-06-2015)
    “…Antisense oligonucleotides are synthetic single stranded strings of nucleic acids that bind to RNA and thereby alter or reduce expression of the target RNA…”
    Get full text
    Journal Article
  20. 20

    Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1 by van der Bent, M. Leontien, Evers, Melvin M, Valles, Astrid

    Published in Biologics (30-09-2022)
    “…Huntington's disease is a devastating heritable neurodegenerative disorder that is caused by the presence of a trinucleotide CAG repeat expansion in the…”
    Get full text
    Journal Article